Xiao D. Zhao
CAS Key Laboratory For Biomedical Effects Of Nanomaterials And Nanosafety, No.11 Zhongguancun Beiyitiao
Beijing, 100190, China
Beijing, 100190, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications
Immunological Conversion of Solid Tumors Using an Outer Membrane Vesicle Based Checkpoint Nanoinhibitor for Cancer Immunotherapy.
Journal: ACS nano
Published: February 02, 2026
Bacterial Outer Membrane Vesicles in Potentiating Cancer Vaccines: Progress and Prospects.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 29, 2025
Engineered Bacterial Therapeutics: Controlled Release Approaches in Oncology.
Journal: Small methods
Published: August 12, 2025
Mesoscopic insights into effects of electric field on pool boiling for leaky dielectric fluids.
Journal: Communications physics
Published: January 07, 2025
Reprogramming tumor-associated macrophages and blocking PD-L1 via engineered outer membrane vesicles to enhance T cell infiltration and cytotoxic functions.
Journal: Journal of nanobiotechnology
Published: January 04, 2025
Engineered bacteria assist CAR-cell immunotherapy.
Journal: Acta pharmaceutica Sinica. B
Published: November 27, 2024
Hybrid Outer Membrane Vesicles with Genetically Engineering for Treatment of Implant-Associated Infections and Relapse Prevention Through Host Immunomodulation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 20, 2024
Bacterial extracellular vesicles for gut microbiome-host communication and drug development.
Journal: Acta pharmaceutica Sinica. B
Published: October 23, 2024
An OMV-Based Nanovaccine as Antigen Presentation Signal Enhancer for Cancer Immunotherapy.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: September 06, 2024
Antigen-Targeting Inserted Nanomicelles Guide Pre-Existing Immunity to Kill Head and Neck Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 02, 2024
Drugless peptide-based nanohybrids alleviate diabetic retinopathy by suppressing microglial activation and endothelial inflammation.
Journal: Theranostics
Published: August 24, 2024
Last Updated: 09/26/2026